The field of organ-on-a-chip has been in existence for 20 years, with the pace of commercialization increasing significantly in the past 5 years. CN Bio Innovations have commercialized single and multi-organ chips based on technology from the lab of Prof L. Griffith at M.I.T. Liver and liver disease models are an attractive target for organ-on-a-chip technologies owing to the relatively rapid dedifferentiation of primary liver cells in 2D culture. In this presentation I will discuss the development and commercialization of CN Bio Innovation’s LiverChip platform together with Quantum B our full viral life cycle model of Hepatitis B infection and look ahead to opportunities for multi-organ systems.
Recommended Videos
Video
Only 17% of the English-language biographies on Wikipedia are about women – but the statistic won’t stay that low for long if Dr Jess Wade has her way. A passionate advocate for diversity in science, Jess balances her work as an award-winning physicist at Imperial College London with her role as a ‘Wikipedian’, creating and uploading the biographies of underrepresented groups in science.
WATCH NOWLike what you just watched? You can find similar content on the communities below.
Drug DiscoveryTo personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free
LOGIN SUBSCRIBE FOR FREE
